Sheba Medical Center's Boston-based accelerator will deploy cutting-edge innovations statewide, potentially transforming ...
The first successful human transplant of a kidney converted from blood type A to universal type O used special enzymes ...
It's been one year since Norton Healthcare became the only hospital in the region to offer high-intensity focused ultrasound ...
Winner of the 2025 ADA Innovation of the Year Award, unlocking a $2B+ diagnostics market with virtually no direct competitors. ST. AUGUSTINE, Fla.--( ...
On Monday, Sept. 29, she became the 709th incisionless brain surgery patient. The medical center celebrated its 700th surgery in August. Novant has completed the most incisionless brain surgeries in ...
Burlington-based Labcorp has launched the first blood-based test cleared by the U.S. Food and Drug Administration (FDA) for ...
A remarkably low translation rate of 0.14% of colorectal cancer (CRC) biomarkers have been approved for patient care. The ...
The U.S. Food and Drug Administration (FDA) has approved its Guardant360® CDx as a companion diagnostic to identify patients ...
An innovative approach could transform the treatment landscape for DLBCL patients, offering hope to those who might otherwise ...
The accuracy of non-invasive blood and stool-based tests for colorectal cancer is improving, but experts say it’s too soon to ...
Learn how to interpret atypical SIBO breath test results—including flat-line, high baseline hydrogen, and delayed motility ...
A genetic test can predict if someone will go on to develop invasive breast cancer after abnormal cells have been found in their breast tissue.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback